|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of sitagliptin,a dipeptidyl peptidase-4 inhibitor,on blood pressure in nondiabetic patients with mild to moderate hypertension显示文摘 | Mistry GC Maes AL Lasseter KC | 2008 | J Clin Pharmcol2008，48，5： | 1 |
| 2 | Effect of sitagliptin, a dipeptidyl peptidase -4 inhibitor, on blood pressure in nondiabetlc patients with mild to moderate hypertension 显示文摘 | Mistry GC Maes AL Lasseter KC | 2008 | J Clin Pharmacol2008，48，： | 1 |
| 3 | Effect of sitagliptin,a dipeptidy 1 peptidase-4 inhibitor,on blood pressure in nondiabetic patients with mild to moderate hypertension显示文摘 | Mistry GC Maes AL Lasseter KO | 2005 | J Clin Pharmacol2005，48，5： | 1 |
| 4 | Single- and multi- ple-dose administration of caspofungin in patients with he- patic insufficiency: implications for safety and dosing rec- ommendations显示文摘 | Mistry GC Migoya E Deutsch PJ | 2007 | J Clin Pharmacol2007，47，8： | 1 |
| 5 | Atazanavir modestly increases plasma levels of raltegravir in healthy subjects显示文摘 | Iwamoto M Wenning LA Mistry GC | 2008 | Clin Infect Dis2008，47，1： | 1 |
| 6 | Evaluation of phar- macokinetic parameters and dipeptidyl peptidase-4 inhibi- tion following single doses of sitagliptin in healthy, young Japanese males 显示文摘 | Herman GA Mistry GC Yi B | 2011 | Br J Clin Pharmacol2011，71，3： | 1 |
| 7 | Safety andpharmacokinetics of higher doses of caspofungin in healthy adultparticipants显示文摘 | Migoya EM Mistry GC Stone JA | 2011 | J Clin Pharmacol2011，51，2： | 1 |
| 8 | Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects显示文摘 | Mistry GC Bergman AJ Zheng W | 2008 | Br J Clin Pharmacol2008，66，1： | 1 |
| 9 | Multiple-dose administration of sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not alter the single?dose pharmacokinetics of rosiglitazone in healthy subjects显示文摘 | Mistry GC Bergman AI Luo WL | 2007 | J Clin Pharmacol2007，47，2： | 1 |
| 10 | Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension显示文摘 | Mistry GC Maes AL Lasseter KC | 2008 | J Clin Pharmacol2008，48，5： | 1 |
| 11 | Dose-proportion- ality of a final market image sitagliptin formulation, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers显示文摘 | BERGMAN A MISTRY GC LUO WL | 2007 | Biop- harm Drug Dispos2007，28，6： | 1 |
| 12 | Single-and multiple-dose administration of caspofungin in patients with hepatic insufficiency: Implications for safety and dosing recommendations显示文摘 | Mistry GC Migoya E Deutsch PJ | 2007 | J Clin Pharmacol2007，47，8： | 1 |
| 13 | Raltegravir thorough QT/QTc study: a single supratherapeutic dose of ral- tegravir does not prolong the QTcF interval显示文摘 | IWAMOTO M KOST JT MISTRY GC | 2008 | J Clin Pharmacol2008，48，6： | 1 |
| 14 | Evaluation of phar- macokinetic parameters and Dipeptidyl Peptidase-4 inhi- bition following single doses of sitagliptin in healthy, young Japanese males 显示文摘 | Herman GA Mistry GC Yi B | 2011 | Br J Clin Pharmacol2011，71，3： | 1 |
| 15 | Sitagliptin,a dipeptidyl peptidase-4 inhibitor,does not alter the pharmacokinetics of the sulphonylurea,glyburide,in healthy subjects显示文摘 | Mistry GC Bergman AJ Zheng W | 2008 | J Clin Pharmacol2008，66，： | 1 |
| 16 | Sitagliptin,adipeptidyl peptidase-4 inhibitor,dose not alter the pharmacokinetics of the sulpholurea,glyburide,in healthy subjects显示文摘 | Mistry GC Bergman AJ Zheng W | 2008 | Br J Clin Pharmacal2008，66，1： | 1 |
| 17 | Multiple-dose administration of sitagliptin,a peptidyl peptidase-4 inhibitor,dose not alter the single-dose pharmacokinetics of rosiglitazone in healthy subjects显示文摘 | Mistry GC Bergman A J Luo WL | 2007 | J Clin Pharmacal2007，47，2： | 1 |
| 18 | Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension 显示文摘 | Mistry GC Maes AL Lasseter KC | 2008 | J Clin Pharmacol2008，48，： | 1 |
| 19 | Effect of sita- gliptin, a dipeptidyl peptidase-4 inhibitor, on blood pres- sure in nondiabetic patients with mild to moderate hyper- tension显示文摘 | Mistry GC Maes' AL Lasseter KC | 2008 | J Clin Pharmacol2008，48，5： | 1 |
| 20 | Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension 显示文摘 | Mistry GC Maes AL Lasseter KC | 2008 | J Clin Pharmacol2008，48，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员